Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Enhancer box (E-box) DNA motif is a specific DNA sequence, characterized by the consensus 5'-CANNTG-3', that acts as a critical cis-regulatory element in the genome. In the nervous system, these motifs are predominantly found within the regulatory regions of genes that drive neuronal differentiation and neurogenesis. They serve as the primary binding sites for basic helix-loop-helix (bHLH) transcription factors, such as NeuroD1, Ascl1 (Mash1), and Atoh1, which are essential for the commitment and maturation of neural progenitor cells (Bertrand et al., 2002). By recruiting these factors, E-boxes facilitate the assembly of transcriptional complexes that activate the expression of downstream neuronal markers and structural proteins (Massari & Murre, 2000). While the E-box itself is a structural component of DNA rather than a protein receptor or enzyme, it is a focal point for understanding gene regulatory networks in health and disease. Dysregulation of the bHLH-E-box interaction is implicated in various conditions, including neurodevelopmental disorders and brain tumors like glioblastoma, where aberrant transcription factor activity drives pathological cell states (Guillemot, 2007). Currently, there are no approved drugs that directly target the E-box motif itself; however, research into small molecules or decoy oligonucleotides that can modulate transcription factor binding remains an area of interest. The ubiquity of E-box sequences across the genome presents a significant challenge for therapeutic specificity, as targeting these motifs could lead to widespread off-target effects in non-neuronal tissues.
Recruitment of basic helix-loop-helix (bHLH) transcription factors to gene regulatory regions to initiate or repress the transcription of neuronal genes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enhancer box DNA motif (E-box).